Annika Scheffold

1.2k total citations
26 papers, 557 citations indexed

About

Annika Scheffold is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Annika Scheffold has authored 26 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Genetics and 8 papers in Hematology. Recurrent topics in Annika Scheffold's work include Chronic Lymphocytic Leukemia Research (10 papers), Telomeres, Telomerase, and Senescence (6 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Annika Scheffold is often cited by papers focused on Chronic Lymphocytic Leukemia Research (10 papers), Telomeres, Telomerase, and Senescence (6 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Annika Scheffold collaborates with scholars based in Germany, United States and Italy. Annika Scheffold's co-authors include Stephan Stilgenbauer, K. Lenhard Rudolph, Billy Michael Chelliah Jebaraj, Dietmar Rudolf Thal, Birgit Liss, André Lechel, Karin M. Danzer, Knut Biber, Yvonne Begus‐Nahrmann and Martina Seiffert and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Brain.

In The Last Decade

Annika Scheffold

24 papers receiving 552 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annika Scheffold Germany 14 234 181 141 99 90 26 557
Reddy Gali United States 9 298 1.3× 80 0.4× 120 0.9× 213 2.2× 22 0.2× 11 655
Idoia García Spain 19 745 3.2× 99 0.5× 142 1.0× 179 1.8× 33 0.4× 28 1.0k
Tracy Busse United States 9 402 1.7× 261 1.4× 55 0.4× 44 0.4× 90 1.0× 11 629
Maria Dimitriadi United Kingdom 14 555 2.4× 72 0.4× 188 1.3× 103 1.0× 26 0.3× 17 857
Hyesook Yoon United States 19 272 1.2× 82 0.5× 351 2.5× 72 0.7× 147 1.6× 30 908
Sébastien Didier United States 12 273 1.2× 128 0.7× 280 2.0× 35 0.4× 184 2.0× 16 713
Naveed Wagle United States 12 325 1.4× 270 1.5× 174 1.2× 106 1.1× 13 0.1× 31 850
Hemant Varma United States 12 305 1.3× 43 0.2× 108 0.8× 77 0.8× 31 0.3× 36 625
Katarzyna Gawęda-Walerych Poland 13 416 1.8× 75 0.4× 27 0.2× 124 1.3× 29 0.3× 22 621
Michela Taiana Italy 13 221 0.9× 105 0.6× 119 0.8× 139 1.4× 22 0.2× 26 517

Countries citing papers authored by Annika Scheffold

Since Specialization
Citations

This map shows the geographic impact of Annika Scheffold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annika Scheffold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annika Scheffold more than expected).

Fields of papers citing papers by Annika Scheffold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annika Scheffold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annika Scheffold. The network helps show where Annika Scheffold may publish in the future.

Co-authorship network of co-authors of Annika Scheffold

This figure shows the co-authorship network connecting the top 25 collaborators of Annika Scheffold. A scholar is included among the top collaborators of Annika Scheffold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annika Scheffold. Annika Scheffold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ng, Yuen Lam Dora, Annika Scheffold, Stefanie Lindner, et al.. (2020). Generation of a lenalidomide-sensitive syngeneic murine in vivo multiple myeloma model by expression of Crbn. Experimental Hematology. 93. 61–69.e4. 3 indexed citations
3.
Scheffold, Annika & Stephan Stilgenbauer. (2020). Revolution of Chronic Lymphocytic Leukemia Therapy: the Chemo-Free Treatment Paradigm. Current Oncology Reports. 22(2). 16–16. 16 indexed citations
4.
Scheffold, Annika, Zhiyang Chen, F Becker, et al.. (2019). Elevated Hedgehog activity contributes to attenuated DNA damage responses in aged hematopoietic cells. Leukemia. 34(4). 1125–1134. 6 indexed citations
5.
Jahn, Nikolaus, Stefanie Lindner, Anna Dolnik, et al.. (2019). Functional characterization of BRCC3 mutations in acute myeloid leukemia with t(8;21)(q22;q22.1). Leukemia. 34(2). 404–415. 16 indexed citations
6.
Roessner, Philipp M., Bola S. Hanna, Selcen Öztürk, et al.. (2019). TBET‐expressing Th1 CD4+T cells accumulate in chronic lymphocytic leukaemia without affecting disease progression in Eµ‐TCL1 mice. British Journal of Haematology. 189(1). 133–145. 13 indexed citations
7.
Scheffold, Annika, Billy Michael Chelliah Jebaraj, Eugen Tausch, et al.. (2019). IGF1R as druggable target mediating PI3K-δ inhibitor resistance in a murine model of chronic lymphocytic leukemia. Blood. 134(6). 534–547. 44 indexed citations
8.
Hanna, Bola S., Philipp M. Roessner, Annika Scheffold, et al.. (2018). PI3Kδ inhibition modulates regulatory and effector T-cell differentiation and function in chronic lymphocytic leukemia. Leukemia. 33(6). 1427–1438. 49 indexed citations
9.
Scheffold, Annika, Billy Michael Chelliah Jebaraj, & Stephan Stilgenbauer. (2018). Venetoclax: Targeting BCL2 in Hematological Cancers. Recent results in cancer research. 212. 215–242. 26 indexed citations
10.
Kraus, Johann M., Annika Scheffold, Thomas F.E. Barth, et al.. (2018). YAP Activation Drives Liver Regeneration after Cholestatic Damage Induced by Rbpj Deletion. International Journal of Molecular Sciences. 19(12). 3801–3801. 18 indexed citations
11.
Scheffold, Annika, Billy Michael Chelliah Jebaraj, Johannes Bloehdorn, et al.. (2017). High IGF1R Expression Is Associated with Worse Prognosis in CLL and Impacts Response to PI3K-δ Inhibitor Treatment. Blood. 130. 390–390.
12.
13.
Jebaraj, Billy Michael Chelliah, Christof Schneider, Jennifer Edelmann, et al.. (2017). Telomere length in poor-risk chronic lymphocytic leukemia: associations with disease characteristics and outcome. Leukemia & lymphoma. 59(7). 1614–1623. 13 indexed citations
14.
Scheffold, Annika, Inge R. Holtman, Sandra Dieni, et al.. (2016). Telomere shortening leads to an acceleration of synucleinopathy and impaired microglia response in a genetic mouse model. Acta Neuropathologica Communications. 4(1). 87–87. 41 indexed citations
15.
Wiesner, Diana, Martina Meßner, Alexander Karabatsiakis, et al.. (2016). Telomere shortening leads to earlier age of onset in ALS mice. Aging. 8(2). 382–393. 29 indexed citations
16.
Ghia, Paolo, Viktor Ljungström, Eugen Tausch, et al.. (2016). Whole-Exome Sequencing Revealed No Recurrent Mutations within the PI3K Pathway in Relapsed Chronic Lymphocytic Leukemia Patients Progressing Under Idelalisib Treatment. Blood. 128(22). 2770–2770. 20 indexed citations
17.
Oeckl, Patrick, Annika Scheffold, André Lechel, K. Lenhard Rudolph, & Boris Ferger. (2014). Substantial telomere shortening in the substantia nigra of telomerase-deficient mice does not increase susceptibility to MPTP-induced dopamine depletion. Neuroreport. 25(5). 335–339. 4 indexed citations
18.
Eschbach, Judith, Kathrin Müller, Hanna Bayer, et al.. (2014). Mutual exacerbation of peroxisome proliferator‐activated receptor γ coactivator 1α deregulation and α‐synuclein oligomerization. Annals of Neurology. 77(1). 15–32. 106 indexed citations
19.
Begus‐Nahrmann, Yvonne, Daniel Hartmann, Johann M. Kraus, et al.. (2012). Transient telomere dysfunction induces chromosomal instability and promotes carcinogenesis. Journal of Clinical Investigation. 122(6). 2283–2288. 41 indexed citations
20.
Rolyan, Harshvardhan, Annika Scheffold, Annette Heinrich, et al.. (2011). Telomere shortening reduces Alzheimer’s disease amyloid pathology in mice. Brain. 134(7). 2044–2056. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Reddy Gali Breakdown of academic impact, for papers by Idoia García Breakdown of academic impact, for papers by Tracy Busse Breakdown of academic impact, for papers by Maria Dimitriadi Breakdown of academic impact, for papers by Hyesook Yoon Breakdown of academic impact, for papers by Sébastien Didier Breakdown of academic impact, for papers by Naveed Wagle Breakdown of academic impact, for papers by Hemant Varma Breakdown of academic impact, for papers by Katarzyna Gawęda-Walerych Breakdown of academic impact, for papers by Michela Taiana
Rankless by CCL
2026